S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

NCT00045162 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

671

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: etoposide
DRUG: irinotecan hydrochloride

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]